Table 2.
Factors and Impact of Inability to Obtain Unfunded Medications for Patients (n = 158)
| Factor | Positive Impact |
No Impact |
Negative Impact |
Do Not Know |
||||
|---|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | No. | % | |
| Inability to obtain expensive unfunded medications for patients has impacted: | ||||||||
| Your physician-patient relationships, trust, credibility | 10 | 6.3 | 85 | 53.8 | 49 | 31.0 | 14 | 8.9 |
| Your patients' clinical outcomes, overall survival, toxicity, and adverse effects | 7 | 4.4 | 33 | 20.9 | 88 | 55.7 | 30 | 19.0 |
| Your patients' perceived psychosocial quality of life, anxiety, depression | 5 | 3.2 | 23 | 14.6 | 115 | 72.8 | 15 | 9.5 |
| Factors that affect patients' drug access | ||||||||
| Patients' low socioeconomic status | 12 | 7.6 | 26 | 16.5 | 116 | 73.4 | 4 | 2.5 |
| Patients having private drug insurance | 138 | 87.3 | 12 | 7.6 | 6 | 3.8 | 2 | 1.3 |
| Media coverage of new cancer drugs | 60 | 38.0 | 75 | 47.5 | 8 | 5.1 | 15 | 9.5 |